13F HOLDINGS REPORT
Ally Bridge Group (NY) LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000950123-23-010736
Total Value
$85.2M
Positions
19
Other Managers
1
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 183,105 | $10.4M | 12.25% |
| 2 | XENON PHARMACEUTICALS INC | XENE | 266,961 | $9.1M | 10.70% |
| 3 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 175,000 | $9.1M | 10.70% |
| 4 | AXSOME THERAPEUTICS INC | AXSM | 110,600 | $7.7M | 9.07% |
| 5 | APELLIS PHARMACEUTICALS INC | APLS | 181,805 | $6.9M | 8.12% |
| 6 | CYTOKINETICS INC | CYTK | 223,382 | $6.6M | 7.72% |
| 7 | MERUS NV | N5749R100 | 221,384 | $5.2M | 6.13% |
| 8 | AMYLYX PHARMACEUTICALS INC | AMLX | 272,690 | $5.0M | 5.86% |
| 9 | GERON CORP | GERN | 2,221,639 | $4.7M | 5.53% |
| 10 | ARDELYX INC | ARDX | 881,356 | $3.6M | 4.22% |
| 11 | AMBRX BIOPHARMA INC | 02290A102 | 281,089 | $3.2M | 3.79% |
| 12 | MIRATI THERAPEUTICS INC | 60468T105 | 70,283 | $3.1M | 3.59% |
| 13 | JASPER THERAPEUTICS INC | JSPRW | 3,144,164 | $2.2M | 2.58% |
| 14 | BLACK DIAMOND THERAPEUTICS I | BDTX | 634,191 | $1.8M | 2.14% |
| 15 | PRAXIS PRECISION MEDICINES I | PRAX | 1,056,370 | $1.8M | 2.12% |
| 16 | COMPASS THERAPEUTICS INC | CMPX | 914,630 | $1.8M | 2.11% |
| 17 | CONTEXT THERAPEUTICS INC | CNTX | 725,951 | $1.1M | 1.29% |
| 18 | PROMIS NEUROSCIENCES INC | PMN | 531,915 | $1.1M | 1.24% |
| 19 | MEDAVAIL HOLDINGS INC | 58406B202 | 117,897 | $707,382 | 0.83% |